Academician Zhao Jizong: In the future, neurosurgery will enter the era of network neurosurgery

Zhao Jizong, an academician of the Chinese Academy of Sciences, the first batch of experts and members of the review committee of China Science and Technology Think Tank, and a member of the Audit Committee, and an expert in neurosurgery. Professor, doctoral supervisor, chief physician of the Department of Neuroscience, Doctor, and Chief Physician of the Beijing Tiantan Hospital of Capital Medical University, and director of the National Neurological Disease Clinical Medicine Research Center.

Zhao Jizong has long been engaged in clinical and basic research on neurosurgery. He presided over the national "Ninth Five -Year Plan" to "Eleventh Five -Year Plan" cerebral vascular disease surgery. The standardized cerebral hemorrhagic surgery technology in China has significantly reduced mortality and has significant economic and social benefits. The first to establish a minimally invasive neurosurgery technology platform has completed the major transfer of neurosurgery from brain anatomy and protection to brain function protection.

Take the lead in establishing encephalopathy minimally invasive neurosurgery technology platform

Stroke is commonly known as "stroke", which is known as the "number one killer" for life and health. China's bleeding stroke accounts for 21%to 48%of all strokes, and the mortality rate is as high as 30%to 50%. In order to improve the efficiency of treatment, the Ministry of Science and Technology established the research and promotion and promotion of stroke standardized surgical treatment in the national research plan. Studies have reduced the mortality rate of Chinese cerebral hemorrhage minimally invasive surgery from 30%to 19.3%. Then he led the team through research to standardize three surgical methods to treat hypertension brain bleeding, and established six six stroke surgery treatment bases that integrate clinical, scientific research, teaching and consulting services. Treatment lays the foundation.

Zhao Jizong said that the world's neurosurgery has experienced three development stages: classic neurosurgery, micro -neurosurgery and minimally invasive neurosurgery. We have taken the lead in establishing a minimally invasive neurosurgery technology platform based on the "precise positioning system of brain lesions anatomy and brain recognition function" and "brain recognition function protection early warning system". He introduced that these two systems are like navigation, which can accurately locate patients in the brain of patients and integrate a series of monitoring technologies such as ultrasonic, cerebral blood flow, vascular fluorescence, and neuropsychiatric to ensure that patients' cognitive functions in anesthesia are not suffered from losses. Essence

With the rise of brain science research, digitalization of medical imaging, and the emergence of composite surgery technology. Zhao Jizong said that in the future, neurosurgery will enter the fourth stage -network neurosurgery. This not only provides a more secure and reliable method for patients with refractory neurological diseases, but also opens a new situation to brain science research and innovation for neurosurgeons. He said that some patients with difficult diseases can present physical conditions through remote videos. Experts give corresponding treatment suggestions through consultation, consulting materials, and discussions. It can also be combined with neurological engineering, nanotechnology, brain -computer interface and other technologies to complete the implantation electrodes, resection lesions and other surgical operations, so as to treat most of the refractory neuropathy, such as chronic pain, motor disorder, epilepsy, mental illness,, mental illness, psychiatric disease,, mental illness, psychiatric disease, Hearing impairment, loss of vision, etc. It is of great significance to patients with severe nervous system diseases.

In addition, the prevention and treatment of cardiovascular and cerebrovascular diseases has always been the focus of my country's medical and health care. To this end, Zhao Jizong proposed the concept of "brain -hearted treatment". He took a patient with two homologous diseases: a patient with two kinds of homologous diseases with cerebrovascular and cardiovascular. The traditional treatment method was treated for a certain disease. The "brain and heart" advocated the synergy of the chest pain center and stroke, while completing the treatment of two organ diseases: brain and heart. He emphasized that China's brain science research is a new opportunity for the development of neuroscience. It requires the cross -disciplinary mechanism to understand the brain, and cooperates with engineering and technical personnel to use medical device development artificial intelligence and brain machine interfaces. Opportunities to launch a clinical study of neurological diseases.

Discipline cross, medical integration, and medical and industrial integration are the direction of life science and technology innovation

At present, many technologies, equipment and drugs in our biomedical fields are from abroad. In the operating room, it is large to the operation of nerve navigation, surgical microscope, anesthesia, and small as small as surgical beds, shadow lamps, clips, etc., and basically come from foreign companies. In particular, some products with high requirements for research and development and production technology are often monopolized by foreign companies. Zhao Jizong believes that one of the important reasons for this status quo is the disconnection of clinical work, scientific research, and transformation of results. And said that multidisciplinary cooperation is the key to solving the problem of "card neck".

Zhao Jizong said that with the current research -oriented hospital construction, it should be done well in the system design, which can maintain the normal operation of the hospital and meet patient needs, but also encourage clinicians to invest in greater experience in scientific research. He suggested that in the clinical field, subject cross and integration must be achieved, the subject restrictions are broken, and the patients are more abundant for patients; secondly, to promote scientific and technological innovation with "medical integration" and "medical integration".

Today, Zhao Jizong is still promoting the development of disciplines. He said: "As a clinician, we should actively invest in clinical studies in brain science and strive to explore unknown areas. Only by continuously learning more cross -disciplinary knowledge and climbing the peak of medicine can we continuously promote clinical medicine to benefit humans." At the same time, he said that in the fourth scientific and technological revolution represented by life technology, the interdisciplinary cross, medical integration, and medical integration are the direction of revolutionary breakthroughs in life technology. (Source: China Science and Technology Think Tank Official WeChat Public Account Text/Wang Huilan)

Academician Zhao Jizong diagnosed the condition for the patient

Related Links:

Introduction to Academician Zhao Jizong

Zhao Jizong, an academician of the Chinese Academy of Sciences, the first batch of experts and members of the review committee of China Science and Technology Think Tank, and a member of the Audit Committee, and an expert in neurosurgery. Professor, doctoral supervisor, chief physician of the Department of Neuroscience, Doctor, and Chief Physician of the Beijing Tiantan Hospital of Capital Medical University, and director of the National Neurological Disease Clinical Medicine Research Center. He has been engaged in clinical and basic research of neurosurgery for a long time. He presided over the national "Ninth Five -Year Plan" to "Eleventh Five -Year Plan" cerebral vascular disease surgery. For the first time, it was found that a huge dynamic venous deformity (-m) broke the time window for normal irrigation pressure, and a huge -M was successfully removed. Keeping key technologies of complex aneurysm surgery, using aneuryspericity specimens to study its formation and rupture mechanism. The standardized cerebral hemorrhagic surgery technology in China has significantly reduced mortality and has significant economic and social benefits. For the first time, the specimen of cerebral hemorrhage has confirmed the incidence of starch -like changes, which provides a basis for the early diagnosis treatment of cerebral hemorrhage. Domestic the first establishment of a minimally invasive neurosurgery technology platform, which has completed the major transfer of neurosurgery from brain anatomy and protection to brain function protection.

He has won the National Science and Technology Progress Award, the Beijing Municipal Health Bureau Science and Technology Award, the Scientific Progress of the Chinese Medical Association, the "Lifetime Achievement Award" of the Chinese Stroke Society, and the Wu Jieping Medical Award. He has been rated as an advanced individual of Beijing Health System, an advanced worker in Beijing Science, an expert in outstanding contributions, Beijing Economic and Technological Innovation Models, an advanced worker of Beijing and the National Health System. Enjoy a special allowance of the State Council. Published 494 papers, 195 SCIs, and 13 editors and publishing monographs.

- END -